TherapeuticsMD shares crater as anticipated M&A deal falls through
Six weeks after announcing an offer to be acquired for nearly $177 million, TherapeuticsMD is now saying the deal is off.
Execs kept it short in a press release, saying proposed buyer EW Healthcare Partners did not acquire the necessary shares to complete the deal by Tuesday night’s deadline. The offer expired as a result, with TherapeuticsMD saying it “intends to maintain normal operations at this time.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 170,400+ biopharma pros reading Endpoints daily — and it's free.